Divestments

Dako

EQT V bought Dako in 2007.

Dako is a world leader in providing systems for cancer diagnostics. Hospital and research laboratories worldwide use Dako reagents, instruments and software to make precise diagnoses and determine the most effective treatment for patients suffering from cancer.

  • Sektor
    Healthcare
  • Land
    Denmark
  • Fond
    EQT V
  • Entry
    2007
  • Exit
    2012-06-01

The company has a long history of market leadership and is highly recognized among pathology laboratories around the world. Dako’s headquarters are located in Denmark and the company has approximately 1,100 employees

In 2012 EQT V sold Dako to Agilent Technologies.

Prenumerera

Prenumerera på EQT:s press releaser, regulatoriska press releaser och updates.

Typ av nyheter
Preferred language
EQT logo
En syftesdriven global investeringsorganisation
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180